# Arbutus Biopharma Corp: Form 8-K, filed Jul 16, 2026

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2026-07-16
- Accepted by EDGAR: Jul 16, 2026, 07:31 ET
- Period: 2026-07-15
- Accession: 0001171843-26-004708
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000117184326004708/f8k_071626.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000117184326004708/

## Items reported

- Item 1.02: Termination of a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000117184326004708/f8k_071626.htm

Filed Jul 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-004708. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
